Associations of Exhaled Carbon Monoxide and Fractional Exhaled Nitric Oxide with Metabolic Syndrome: A Cohort Study
Open Access
- 14 April 2016
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 24532
Abstract
Exhaled carbon monoxide (eCO) and fractional exhaled nitric oxide (FeNO) could reflect underlying inflammatory and oxidative stresses, which play important roles in pathogenetic pathways of metabolic syndrome (MetS). However, epidemiologic evidence was limited. We conducted a study in Wuhan-Zhuhai (WHZH) cohort of 3649 community participants to investigate the association between eCO, FeNO and MetS in both cross-sectional and prospective ways. The results showed that higher eCO and FeNO were associated cross-sectionally with a higher prevalence of MetS. The multivariable-adjusted odds ratios for MetS at baseline were 1.22 (95% confidence interval [CI]: 1.11 to 1.35) associated with per log eCO and 1.14 (95% CI: 1.00 to 1.30) associated with per log FeNO. During a follow-up of 3 years, 358/2181 new developed MetS cases were identified. Compared with lowest quartile of eCO and FeNO, the multivariable-adjusted risk ratios (95% CI) for MetS were 1.48 (1.06 to 2.06) related to the highest quartile of eCO. These findings remained consistent across sex but not smoking status, eCO was only associated with MetS in non-smokers when stratified by smoking status. In conclusion, our study demonstrated that eCO and FeNO were independently and positively associated with the prevalence of MetS cross-sectionally, while only eCO was positively related with the incidence of MetS prospectively.Keywords
This publication has 42 references indexed in Scilit:
- Association of exhaled carbon monoxide with subclinical cardiovascular disease and their conjoint impact on the incidence of cardiovascular outcomesEuropean Heart Journal, 2014
- Fractional Exhaled Nitric Oxide in Healthy Tibetans at High AltitudeMedical Science Monitor, 2014
- The clinical potential of exhaled breath analysis for diabetes mellitusDiabetes Research and Clinical Practice, 2012
- Exhaled nitric oxide and atherosclerosisEuropean Journal of Clinical Investigation, 2012
- The role of carbon monoxide in metabolic diseaseAnnals of the New York Academy of Sciences, 2011
- Heme Oxygenase-1 and Carbon Monoxide in Vascular PathobiologyCirculation, 2008
- Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological ApplicationsPharmacological Reviews, 2005
- Role of nitric oxide and cyclooxygenase pathways in the coronary vascular effects of halothane, isoflurane and desflurane in red blood cell-perfused isolated rabbit heartsBritish Journal of Anaesthesia, 2002
- Interrelation between Oxygen Tension and Nitric Oxide in the Respiratory SystemAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Exhaled Carbon Monoxide Levels Elevated in Diabetes and Correlated With Glucose Concentration in BloodChest, 1999